In Luminal A breast cancer, bulk FOXC1 reports the tumour vasculature, while a proliferation-independent basal-lineage axis marks the tumour cells
It is shown that bulk FOXC1 is principally a readout of the tumour vasculature rather than the malignant cells, while a genuine basal-lineage axis persists in the tumour cells, and that compartment-aware analysis is needed to interpret bulk transcriptomic biomarkers in compositionally heterogeneous tumours.